# Vaccination With Autologous, Lethally Irradiated Melanoma Cells Engineered by Adenoviral Mediated Gene Transfer to Secrete Granulocyte-Macrophage Stimulating Factor (GMSF)

> **NCT00809588** · PHASE1 · COMPLETED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 84 (actual)

## Conditions studied

- Melanoma

## Interventions

- **BIOLOGICAL:** Autologous, lethally irradiated melanoma cells

## Key facts

- **NCT ID:** NCT00809588
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10-16
- **Primary completion:** 2016-09
- **Final completion:** 2020-02-25
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2024-08-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00809588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00809588, "Vaccination With Autologous, Lethally Irradiated Melanoma Cells Engineered by Adenoviral Mediated Gene Transfer to Secrete Granulocyte-Macrophage Stimulating Factor (GMSF)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00809588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*